Patient satisfaction with midazolam nose spray versus diazepam rectiole.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28858

Enrollment

Registered

2011-04-28

Start date

2010-04-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

midazolam nose spray diazepam rectiole patient satisfaction midazolam neusspray diazepam rectiole patienttevredenheid

Interventions

Patients using either midazolam nose spray or diazepam rectiole for treatment of epileptic seizures, are asked to fill in a treatment satisfaction questionnaire of medication. No intervention will be

Eligibility

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years, either sex; 2. Epilepsia.

Exclusion criteria

Exclusion criteria: 1. Patients with large facial injuries; 2. Evident pregnant; 3. Patients with eclampsia; 4. No command of the Dutch language on written and spoken.

Design outcomes

Primary

Measure	Time frame
Patient satisfaction.	—

Secondary

Measure	Time frame
Influence of several covariates of patients.	—

Contacts

Public ContactN. Veldhorst-Janssen

PO Box 5800

n.veldhorst@mumc.nl+31 (0)43 3876543

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)